Haiyi Deng

429 total citations
33 papers, 246 citations indexed

About

Haiyi Deng is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Haiyi Deng has authored 33 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Haiyi Deng's work include Cancer Immunotherapy and Biomarkers (17 papers), Lung Cancer Treatments and Mutations (16 papers) and Lung Cancer Research Studies (14 papers). Haiyi Deng is often cited by papers focused on Cancer Immunotherapy and Biomarkers (17 papers), Lung Cancer Treatments and Mutations (16 papers) and Lung Cancer Research Studies (14 papers). Haiyi Deng collaborates with scholars based in China, United States and Japan. Haiyi Deng's co-authors include Chengzhi Zhou, Xinqing Lin, Xiaohong Xie, Yinyin Qin, Zhanhong Xie, Ming Liu, Yong Song, Jianhui Wu, Suyang Li and Maolin Zhou and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Frontiers in Immunology.

In The Last Decade

Haiyi Deng

32 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haiyi Deng China 10 172 151 34 26 24 33 246
David Vicente Baz Spain 10 173 1.0× 138 0.9× 52 1.5× 17 0.7× 40 1.7× 27 235
Silvana Acquafredda Italy 6 159 0.9× 94 0.6× 42 1.2× 24 0.9× 43 1.8× 8 237
James Haberberger United States 9 119 0.7× 103 0.7× 39 1.1× 26 1.0× 24 1.0× 18 204
M. Dómine Gómez Spain 9 210 1.2× 128 0.8× 73 2.1× 19 0.7× 52 2.2× 36 277
Ina Valeria Zurlo Italy 6 105 0.6× 89 0.6× 36 1.1× 42 1.6× 13 0.5× 24 191
Lina Inagaki Japan 7 165 1.0× 87 0.6× 54 1.6× 27 1.0× 14 0.6× 14 327
Ying Cheng China 8 211 1.2× 102 0.7× 64 1.9× 16 0.6× 31 1.3× 48 269
Stefano Panni Italy 7 141 0.8× 61 0.4× 15 0.4× 32 1.2× 27 1.1× 23 182
Bharathi Vennapusa United States 6 237 1.4× 106 0.7× 32 0.9× 31 1.2× 66 2.8× 15 312
Kakeru Hisakane Japan 10 179 1.0× 215 1.4× 77 2.3× 27 1.0× 13 0.5× 35 336

Countries citing papers authored by Haiyi Deng

Since Specialization
Citations

This map shows the geographic impact of Haiyi Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyi Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyi Deng more than expected).

Fields of papers citing papers by Haiyi Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiyi Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyi Deng. The network helps show where Haiyi Deng may publish in the future.

Co-authorship network of co-authors of Haiyi Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Haiyi Deng. A scholar is included among the top collaborators of Haiyi Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiyi Deng. Haiyi Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Fei, Haiyi Deng, Maolin Zhou, et al.. (2025). Anti-PD-1 exacerbates bleomycin-induced lung injury in mice via Caspase-3/GSDME-mediated pyroptosis. Cell Death and Disease. 16(1). 3–3. 1 indexed citations
2.
Yang, Yi, Li Yang, Haiyi Deng, et al.. (2025). Coptis chinensis-derived extracellular vesicle-like nanoparticles delivered miRNA-5106 suppresses NETs by restoring zinc homeostasis to alleviate colitis. Journal of Nanobiotechnology. 23(1). 444–444. 5 indexed citations
3.
Bao, Ji, Changhao Zhong, Haiyi Deng, et al.. (2025). Uncovering the immune mechanisms underlying the emergence of immunotherapy-induced pneumonitis in lung cancer patients. Nature Communications. 16(1). 11645–11645.
4.
Li, Ru, Haiyi Deng, Qingyang Li, et al.. (2024). The prognostic impact of severe grade immune checkpoint inhibitor related pneumonitis in non-small cell lung cancer patients. Frontiers in Oncology. 14. 1372532–1372532. 1 indexed citations
5.
Hu, Minjuan, et al.. (2024). Cyclosporine successfully treats steroid-resistant checkpoint inhibitor-related pneumonitis: a case report. BMC Pulmonary Medicine. 24(1). 577–577. 1 indexed citations
6.
Luan, Tao, Yingying Gu, Ping He, et al.. (2024). A clinical analysis and literature review of eleven cases with primary pulmonary angiosarcoma. BMC Cancer. 24(1). 1597–1597. 2 indexed citations
7.
Lin, Xinqing, et al.. (2023). Successful management of Epstein‑Barr virus‑associated severe checkpoint inhibitor‑related pneumonitis: A case report. Experimental and Therapeutic Medicine. 25(5). 222–222. 1 indexed citations
8.
Wang, Fei, Xiaohong Xie, Ting Liu, et al.. (2023). A retrospective real‐world experience of immunotherapy in patients with extensive stage small‐cell lung cancer. Cancer Medicine. 12(14). 14881–14891. 11 indexed citations
9.
Deng, Haiyi, Xinqing Lin, Ziying Lin, et al.. (2023). A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case–Control Study. Clinical Drug Investigation. 43(5). 347–357. 7 indexed citations
10.
Wang, Fei, Xiaohong Xie, Liqiang Wang, et al.. (2023). Real-world data on severe lung cancer: a multicenter retrospective study. Translational Lung Cancer Research. 12(3). 460–470. 3 indexed citations
11.
Xie, Xiaohong, Maolin Zhou, Liqiang Wang, et al.. (2023). Effects of combining immune checkpoint inhibitors and anti-angiogenic agents on bone metastasis in non-small cell lung cancer patients. Human Vaccines & Immunotherapeutics. 19(2). 2241310–2241310. 5 indexed citations
12.
Xie, Xiaohong, Bingpeng Guo, Haiyi Deng, et al.. (2022). Comprehensive characterization reveals sputum supernatant as a valuable alternative liquid biopsy for genome profiling in advanced non-small cell lung cancer. Respiratory Research. 23(1). 175–175. 6 indexed citations
13.
Lin, Xinqing, Haiyi Deng, Yi‐Lin Yang, et al.. (2022). Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis. Frontiers in Immunology. 12. 818492–818492. 20 indexed citations
14.
Lin, Xinqing, Tingting Lü, Haiyi Deng, et al.. (2021). Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases. Journal of Neurology. 269(2). 815–823. 10 indexed citations
15.
Xie, Xiaohong, Haiyi Deng, Xinqing Lin, et al.. (2021). Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient With Non-Small Cell Lung Cancer. Frontiers in Oncology. 11. 673877–673877. 10 indexed citations
16.
Lin, Xinqing, Haiyi Deng, Likun Chen, et al.. (2021). Clinical types of checkpoint inhibitor-related pneumonitis in lung cancer patients: a multicenter experience. Translational Lung Cancer Research. 10(1). 415–429. 12 indexed citations
17.
Lin, Xinqing, Haiyi Deng, Jianhui Wu, et al.. (2021). Peripheral Blood Biomarkers for Early Diagnosis, Severity, and Prognosis of Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer. Frontiers in Oncology. 11. 698832–698832. 50 indexed citations
18.
Deng, Haiyi, Xinqing Lin, Xiaohong Xie, et al.. (2021). Immune Checkpoint Inhibitors Plus Single-Agent Chemotherapy for Advanced Non-Small-Cell Lung Cancer After Resistance to EGFR-TKI. Frontiers in Oncology. 11. 700023–700023. 5 indexed citations
19.
Deng, Haiyi & Chengzhi Zhou. (2021). From CheckMate 227 to CheckMate 9LA: rethinking the status of chemotherapy in the immunotherapy era—chemo-free or chemo-reform?. Translational Lung Cancer Research. 10(4). 1924–1927. 9 indexed citations
20.
Wang, Fei, Xiaohong Xie, Mengmeng Song, et al.. (2020). Tumor immune microenvironment and mutational analysis of tracheal adenoid cystic carcinoma. Annals of Translational Medicine. 8(12). 750–750. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Vicente Baz Breakdown of academic impact, for papers by Silvana Acquafredda Breakdown of academic impact, for papers by James Haberberger Breakdown of academic impact, for papers by M. Dómine Gómez Breakdown of academic impact, for papers by Ina Valeria Zurlo Breakdown of academic impact, for papers by Lina Inagaki Breakdown of academic impact, for papers by Ying Cheng Breakdown of academic impact, for papers by Stefano Panni Breakdown of academic impact, for papers by Bharathi Vennapusa Breakdown of academic impact, for papers by Kakeru Hisakane
Rankless by CCL
2026